$4.12
-0.17-3.96%
Last update: Nov 10, 10:13 AM
CollPlant Biotechnologies Ltd
CLGNNASDAQ
CollPlant Biotechnologies rose 118.9% from $1.96 to $4.29, ahead of the S&P 500's +10.5%. Its worst day was Feb 5 (−53.4%), and its low came Aug 4 at $0.29.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-25.00 missed the $25.00 estimate on $77,000.00 revenue (est. $13.7M).
+0.9% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $-25.00 missed the $-19.00 estimate on $60,000.00 revenue (est. $6.8M).
−12.0% · S&P 500 −1.8%
EPS of $-21.00 beat the $-24.00 estimate on $73,000.00 revenue (est. $1.4M).
−0.7% · S&P 500 +0.2%
CollPlant Biotechnologies closed at its lowest level of the year, 85.4% below where the year started.
−9.8% · S&P 500 +1.8%
CollPlant Biotechnologies shares rose 893.9%, while the S&P 500 rose 1.0%.
+893.9%, the year's best day · S&P 500 +1.0%
CollPlant Biotechnologies closed at its highest level of the year, 132.7% above where the year started.
+9.6% · S&P 500 +0.1%
EPS of $-1.69 missed the $-0.24 estimate on $108,000.00 revenue (est. $1.5M).
−3.5% · S&P 500 +0.2%
Where it ended: a close of $4.29 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 25, 2026.
Nothing in the past 12 months.
All CLGN dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CLGN and SPY from Benzinga historical bars. Not investment advice.
